Search - tctmd.com

September 03, 2020

News Opinion CV Team Dispatch

September 2020 News Roundup

L.A. McKeown

September 01, 2020

News Conference News ESC 2020

Acute MI Patients With Anemia May Require Fewer RBC Transfusions: REALITY

September 01, 2020

News Daily News

Higher BP May Limit Myocardial Injury in AMICS

August 10, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

FFR Deferral of Nonculprit Lesions Riskier in ACS vs Stable Angina

August 03, 2020

News Daily News

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

June 30, 2020

News Daily News

Worldwide Drop in STEMI During COVID-19, ESC Survey Confirms

June 09, 2020

News Features

Cardiology After COVID-19: Physicians Predict Lasting Change

May 20, 2020

News Daily News

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

April 27, 2020

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

March 10, 2020

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

February 28, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News Daily News

BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns

February 21, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Todd Neale

January 15, 2020

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

December 20, 2019

News Daily News

Oxygen of No Benefit, Even in MI Patients With Low-Normal Saturation

December 16, 2019

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

December 10, 2019

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

December 09, 2019

News Conference News AHA 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies